These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3 AND Clinical Outcome
774 results:

  • 1. Risk of recurrence in high-risk T1 colon cancer following endoscopic and surgical resection: registry-based cohort study.
    Nilsson E; Wetterholm E; Syk I; Thorlacius H; Rönnow CF
    BJS Open; 2024 May; 8(3):. PubMed ID: 38869239
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Impact of Neoadjuvant Radiochemotherapy on Pathological Complete Response for Locally Advanced Rectal cancer: A Mono Institutional Experience.
    Lucarelli M; Gentile V; Bonelli R; Pasquale G; Pizzi AD; Nicola MD; Porreca A; Genovesi D
    In Vivo; 2024; 38(3):1367-1374. PubMed ID: 38688610
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Spreading Through Air Spaces And Thinking About Lung Metastases.
    M Castro P; Rei J; Silva C; Miranda J; Guerra M
    Port J Card Thorac Vasc Surg; 2023 Oct; 30(3):31-35. PubMed ID: 38499034
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Application Value of High-Quality Nursing in Operating Room in Rectal cancer Operation and its Influence on Postoperative Rehabilitation.
    Liu J; Tan F; Zhang Y; Zhou P; Qian Q; He Q; Xu J
    Surg Innov; 2024 Jun; 31(3):274-285. PubMed ID: 38468453
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [clinical outcome of Five Patients with Perforated colorectal cancer].
    Jinushi K; Ikenaga M; Odagiri K; Yanagimoto Y; Yamashita M; Takeyama H; Suzuki Y; Kawase T; Shimizu J; Imamura H; Dono K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1566-1568. PubMed ID: 38303343
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?
    Herrera-Martínez AD; Román ÁR; Corrales EP; Idrobo C; Ramírez PP; Rojas PM; Lázaro CR; Araujo-Castro M
    Front Endocrinol (Lausanne); 2023; 14():1335202. PubMed ID: 38264281
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Does commission on cancer (CoC) accreditation mitigate the effect of care fragmentation on clinical outcome in localized rectal cancer?
    Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
    Am J Surg; 2024 Apr; 230():63-67. PubMed ID: 38148258
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The age-related obesity paradigm: results from two large prospective cohort studies.
    Ge YZ; Liu T; Deng L; Zhang Q; Liu CA; Ruan GT; Xie HL; Song MM; Lin SQ; Yao QH; Shen X; Shi HP;
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):442-452. PubMed ID: 38146198
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Transanal minimally invasive surgery for benign and malignant rectal lesions: midterm outcomes from a tertiary center.
    Al-Dhaheri M; Al-Ishaq F; Toffaha A; Nada MA; Parvaiz A; Kurer M
    Ann Saudi Med; 2023; 43(6):348-351. PubMed ID: 38071443
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. CT versus MR guidance for radiofrequency ablation in patients with colorectal liver metastases: a 10-year follow-up favors MR guidance.
    Pereira PL; Siemou P; Rempp HJ; Hoffmann R; Hoffmann RT; Kettenbach J; Clasen S; Helmberger T
    Eur Radiol; 2024 Jul; 34(7):4663-4671. PubMed ID: 38041717
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting.
    Saberzadeh-Ardestani B; Jones JC; McWilliams RR; Tougeron D; Halfdanarson TR; Guimbaud R; Hubbard JM; Flecchia C; Shi Q; Alouani E; Sonbol MB; Ticku J; Jin Z; Taieb J; Sinicrope FA
    Eur J Cancer; 2024 Jan; 196():113433. PubMed ID: 37979306
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Association between insulin resistance related indicators with the prognosis of patients with colorectal cancer.
    Yang M; Zhang Q; Ge YZ; Tang M; Zhang X; Song MM; Ruan GT; Zhang XW; Zhang KP; Shi HP
    Cancer Epidemiol; 2023 Dec; 87():102478. PubMed ID: 37856934
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. N6-methyladenosine reader protein IGF2BP1 suppresses CD8 + T cells-mediated tumor cytotoxicity and apoptosis in colon cancer.
    Peng Y; Zhang Z; Yang G; Dai Z; Cai X; Liu Z; Yun Q; Xu L
    Apoptosis; 2024 Apr; 29(3-4):331-343. PubMed ID: 37848671
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comprehensive genomic characterization of sporadic synchronous colorectal cancer: Implications for treatment optimization and clinical outcome.
    Yang LP; Jiang TJ; He MM; Ling YH; Wang ZX; Wu HX; Zhang Z; Xu RH; Wang F; Yuan SQ; Zhao Q
    Cell Rep Med; 2023 Oct; 4(10):101222. PubMed ID: 37794586
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Similar success rate in proximal and distal colonic stent placement: a retrospective multi-center study.
    Basiliya K; Galanopoulos M; Papaefthymiou A; Webster G; Carroll N; Fearnhead NS; Corbett G
    Scand J Gastroenterol; 2024; 59(1):108-111. PubMed ID: 37694882
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Curative pelvic exenteration: initial experience and clinical outcome.
    Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F
    Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Autologous natural killer cells as a promising immunotherapy for locally advanced colon adenocarcinoma: Three years follow-up of resectable case.
    Bagus BI
    Cancer Rep (Hoboken); 2023 Sep; 6(9):e1866. PubMed ID: 37439389
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Technique, sedation, and clinical outcome of endoscopic submucosal dissection for rectal tumor with involvement of dentate line: A retrospective cohort study.
    Noh YK; Lee J; Kim SJ
    Saudi J Gastroenterol; 2023; 29(6):365-370. PubMed ID: 37282445
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer.
    Ryoo SB; Heo S; Lim Y; Lee W; Cho SH; Ahn J; Kang JK; Kim SY; Kim HP; Bang D; Kang SB; Yu CS; Oh ST; Park JW; Jeong SY; Kim YJ; Park KJ; Han SW; Kim TY
    Br J Cancer; 2023 Aug; 129(2):374-381. PubMed ID: 37280413
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Generate Analysis-Ready Data for Real-world Evidence: Tutorial for Harnessing Electronic Health Records With Advanced Informatic Technologies.
    Hou J; Zhao R; Gronsbell J; Lin Y; Bonzel CL; Zeng Q; Zhang S; Beaulieu-Jones BK; Weber GM; Jemielita T; Wan SS; Hong C; Cai T; Wen J; Ayakulangara Panickan V; Liaw KL; Liao K; Cai T
    J Med Internet Res; 2023 May; 25():e45662. PubMed ID: 37227772
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 39.